Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.440 +0.030 (+2.13%)
Official Closing Price Updated: 4:15 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ocugen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
Recap: Ocugen Q3 Earnings ↗
 
Via Benzinga
News headline image
Earnings Outlook For Ocugen ↗
 
Via Benzinga
News headline image
Why Is Archer Aviation (ACHR) Stock Moving Today? ↗
Archer Aviation stock is on a wild ride Tuesday morning after a short report targeting one of its rivals sent ACHR shares down this morning. 
Via InvestorPlace
News headline image
Why Is Ocugen (OCGN) Stock Up 5% Today? ↗
Ocugen stock is rising higher on Tuesday thanks to OCGN investors celebrating news of a new clinical trial for its Covid-19 vaccine. 
Via InvestorPlace
News headline image
Ocugen (OCGN) Q2 2023 Earnings Call Transcript ↗
OCGN earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
A Preview Of Ocugen's Earnings ↗
 
Via Benzinga
News headline image
3 Millionaire-Maker Growth Stocks to Buy Before the Window ↗
Although millionaire-maker stocks to buy present wildly outrageous risks, the intrepid may find opportunity in these ideas. 
Via InvestorPlace
News headline image
Can Pat Toomey Save Ocugen (OCGN) Stock? ↗
Shares of OCGN stock received a boost this morning following the addition of some high-profile names to Ocugen's advisory board. 
Via InvestorPlace
News headline image
Ocugen (OCGN) Q1 2023 Earnings Call Transcript ↗
OCGN earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
Ocugen: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
7 Biotech Stocks to Sell in July ↗
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July. 
Via InvestorPlace
News headline image
7 Doomed Growth Stocks Destined for Disaster ↗
Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell. 
Via InvestorPlace
News headline image
Ocugen And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗
The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
News headline image
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy? ↗
These companies haven't given up on the coronavirus vaccine market. 
Via The Motley Fool
News headline image
5 Investors Betting Big on Ocugen (OCGN) Stock Right Now ↗
Ocugen has been falling after announcing a new share offering. But that's not the only reason hedge funds are moving away from OCGN stock. 
Via InvestorPlace
News headline image
Earnings Outlook For Ocugen ↗
 
Via Benzinga
News headline image
Analyst Ratings for Ocugen ↗
 
Via Benzinga
News headline image
Ocugen Highlights Interim Data From Gene Therapy Study For Genetic Vision Loss Disorder ↗
 
Via Benzinga
News headline image
Crude Oil Rises 2%; Kohl's Reports Surprise Q1 Profit ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 250 points on Wednesday. The Dow traded down 0.73% to 32,813.21 while the NASDAQ fell 0.77% to 12,463.32. The S&P... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Down 1%; US Crude Oil Inventories Decline Last Week ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.72% to 32,816.38 while the NASDAQ fell 1.12% to 12,419.97. The... 
Via Benzinga
News headline image
Why Is Apexigen (APGN) Stock Up 31% Today? ↗
Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS). 
Via InvestorPlace
News headline image
Why Is Ocugen (OCGN) Stock Down 22% Today? ↗
Ocugen (OCGN) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares. 
Via InvestorPlace
News headline image
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning! 
Via InvestorPlace
News headline image
Earnings Scheduled For May 5, 2023 ↗
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday's session saw 286 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 147 stocks made new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.